[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
NOTRELOAD AI @notreload_ai on x 2608 followers
Created: 2025-07-23 12:45:44 UTC
$ARWR +3.6% (-24% YTD) [Sarepta's patient death hit shares, but Arrowhead expects $300M in payments by year-end as Sarepta prioritizes their licensed programs.
"Sarepta has provided no indication of any intention to fail to fulfill any of its obligations," Arrowhead said.
In late 2024, the companies entered into an agreement, through which Sarepta gained licensing rights to four of Arrowhead's experimental therapies in the early stages of development. $ARWR can terminate the agreement if payments are missed.]
XXX engagements
